Medibank (ASX:MPL) share price lifts despite rumours of failed hospital bid

Here are all the details on Medibank's supposed failed acquisition.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Medibank share price is up 0.7% today, trading at $3.23
  • That's despite reports the company's rumoured acquisition of a stake in Cura Group has failed
  • It was previously reported the insurer was planning to announce the purchase before the release of its half year results

The Medibank Private Ltd (ASX: MPL) share price is in the green today despite talk its bid for day hospital operator Cura Group, has fallen through.

Previously, it was reported the private health insurer might have been gearing up to release news of the acquisition in time for its half year results – set to drop next Friday.

At the time of writing, the Medibank share price is $3.23, 0.78% higher than its previous close.

For comparison, the S&P/ASX 200 Index (ASX: XJO) has slipped 0.8% this morning.

Let's take a look at the latest rumours surrounding Medibank.

Private health insurance diagram.

Image source: Getty Images

Medibank's rumoured acquisition falls through

The Medibank share price appears unfazed by rumours its acquisition of private day hospital asset Cura has failed.

The private insurer was previously reported to have agreed to buy a stake in the business for an undetermined amount.

However, The Australian today reported the deal has been abandoned prior to settling.

Cura owns day hospitals in every Australian state and in the Australian Capital Territory (ACT).

Its crown jewels include Barton Private Hospital, Sydney Day Surgery Prince Alfred, and Somerset Private Hospital.

According to the publication, while the proposed acquisition's cost was unknown, when Fresenius Medical Care purchased its majority holding in Cura – reported to be 70% – in 2017, it valued the hospital operator at $400 million.

While the publication didn't confirm how big of a stake in Cura that Medibank was rumoured to be purchasing, Fresenius Medical Care hit back at initial reports it was offloading any of its stake. The company said:

Fresenius Medical Care is strongly committed to long-term ownership and continues to be deeply invested in growing the Cura Day Hospitals business. There is no plan to change this approach in the foreseeable future.

Medibank share price snapshot

While it's gaining today, this year so far has been rough on the Medibank share price.

It has fallen 5% since the start of 2022.

Though, it's currently 14% higher than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Two ASX share investors sharing a secret.
Healthcare Shares

Cochlear shares are quietly rebounding: Is a bigger rally coming?

After a 58% plunge, Cochlear doesn’t need perfection to surprise investors.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

This ASX biotech is tipped to more than double in value

Encouraging trial results have the analysts excited.

Read more »

person climbing mountain
Healthcare Shares

CSL share price forecast: How high could it climb in the next year?

CSL shares could roar back, but investors need more than hope.

Read more »

Two CEOs shaking hands on a deal.
Healthcare Shares

Integral Diagnostics: FY26 results and new CFO appointment

Integral Diagnostics delivered double-digit profit growth and appointed a new CFO.

Read more »

Woman looking at stock market numbers.
Healthcare Shares

CSL shares are rising: 3 things investors need to watch

CSL’s FY26 result could reveal whether the turnaround has finally begun.

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

Why ResMed shares are tumbling 6% today despite strong results

Here's what spooked investors.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Imricor Medical Systems shares: Philips declares compatibility for iMR products

Big news is catching the eye of investors on Friday.

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Earnings Results

ResMed posts strong Q4 earnings, lifts dividend

The sleep disorder treatment company had another record quarter.

Read more »